Science

 PSYBIO THERAPEUTICS  AND MIAMI UNIVERSITY: 

​

SOLVING THE CHALLENGE OF CLINICAL SCALE PRODUCTION

​

Current methods remain tedious and costly

Involving numerous intermediate separation and purification steps resulting in an

the overall yield of 49% from 4-hydroxy indole (Shirota et al., 2003), incurring

an estimated cost of $2000 per gram for pharmaceutical-grade psilocybin

(Fricke et al., 2019).

​

Platform technology enables rapid generation

Of additional psychoactive compounds with distinct desirable properties.

​

Utilizing our proprietary platform technology

Our solution is cheaper, faster, cleaner, and greener. Patent-pending

process of using pharmaceutically scalable prokaryotic hosts. Genetic

optimization has resulted in a 32-fold improvement in psilocybin yield.